Form 4 for EDIT Editas Medicine, Inc.
Accepted 2025-09-04 00:00:00 ET · period of report 2025-09-03 · accession 0001650664-25-000141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-04 | 2025-09-03 | EDIT | O'Neill Gilmore Neil | CEO, Dir | S - Sale | $2.60 | -5,592 | 274.7K | -2% | -$14.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-03 | S | D | 5,592 | $2.60 | 274,690 | D | — | — |